Kidney Month is my Kidney-versary: Why Innovation Matters
My kidneys started failing when I was just five years old. Decades later, ongoing innovation has kept me alive. This National Kidney Month, let’s celebrate progress and push for policies that ensure treatment advances are affordable and accessible. Learn more at https://www.nopatientleftbehind.org/protect-innovation.
Meet NPLB’s New Executive Director
In her first message as Executive Director, Priscilla VanderVeer discusses No Patient Left Behind’s commitment to patient access, innovation, and policy credibility.
8 Ways to Modernize the FDA
Our modern world needs a modern Food and Drug Administration (FDA). As PDUFA VIII offers a historic opportunity to make the drug review program faster, more consistent, and more transparent, here are a few suggestions we heard from our network of experts.
5 ways Biden’s SOTU could advance biotech affordability and innovation
Here are five policies President Biden should include in his State of the Union address on Thursday.
Measuring the damage: IRA’s impact on small molecule drug development
Read what one oncology executive discovered when he surveyed the biotech community.